In magnetic resonance imaging (MRI) of the breast, contrast enhancements present as mass or nonmass (NM) lesions. This study aimed to test the usefulness of currently accepted T1-weighted Breast Imaging Reporting and Data System predictors and to determine the incremental value of new T2-weighted predictors for differentiation of benign from malignant NM lesions.
Consecutive patients undergoing surgery after MRI (1.5-T contrast-enhanced T1- and T2-weighted images) were investigated. Lesions were rated by 2 observers in consensus. Breast Imaging Reporting and Data System criteria for NM included spatial distribution, internal enhancement, and dynamic enhancement pattern. Additional criteria on T2-weighted images were signal intensity, presence of intraductal fluid, or cysts at the enhancements location. Independent differentiation criteria (benign vs malignant) were identified by logistic regression followed by receiver operating characteristics analysis.
Of 316 patients, 65 demonstrated NM. The NM lesions were split almost equally into malignant (34) and benign (31) histology. Breast Imaging Reporting and Data System predictors did not differentiate benign from malignant lesions, whereas signal intensity and the presence of cysts on contrast-enhanced T2-weighted images did, with a sensitivity of 91.2% and a specificity of 64.5%.
Differentiation of NM can be improved using additional T2-weighted images.
From the Institute of Diagnostic and Interventional Radiology, Friedrich Schiller University Jena, Jena, Germany.
Received for publication November 24, 2010; accepted January 14, 2011.
Reprints: Pascal A.T. Baltzer, MD, Institute of Diagnostic and Interventional Radiology, Friedrich Schiller University Jena, Erlanger Allee 101, D-07740 Jena, Germany (e-mail: email@example.com).